Instadose Pharma Stock Price, News & Analysis
Company Description
Instadose Pharma (OTC Link: INSD) is a publicly traded drug manufacturers - specialty & generic company in the Healthcare sector. The company has a market capitalization of $585.1K.
INSD stock has gained 0.0% over the past year. Shares last traded at $0.0000.
This page provides a comprehensive overview of INSD stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Instadose Pharma (INSD) stock last traded at $0.0000. At a market capitalization of $585.1K, INSD is classified as a micro-cap stock with approximately 531.9M shares outstanding.
Latest News
Instadose Pharma has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 1 with negative movement. Key topics include management. View all INSD news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
INSD Company Profile & Sector Positioning
Instadose Pharma (INSD) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing INSD often look at related companies in the same sector, including Ionic Brands (IONKF), Neutra Corp (NTRR), Pharmagreen Biotech Inc (PHBI), Cannabis Global Inc (CBGL), and Grapefruit Usa Inc (GPFT). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate INSD's relative position within its industry.